[Changes in the quality of life influenced by treatment of primary arterial hypertension].
The quality of life (QL) in 90 male patients (age 41.2 +/- 41) suffering from Ist IInd hemodynamic WHO-stage of essential arterial hypertension has been studied during 3 months therapy. The patients have been divided into 3 groups treated with enalapril, atenolol and verapamil respectively. The Sickness Impact Profile, Bulpitt's test and Spitzer's test were used for evaluation of QL. Significant reduction in diastolic arterial blood pressure has been achieved during the treatment period. In the same time improvement in QL indices was observed, most evident in group of enalapril, moderate in group of verapamil and the minor in atenolol group. It is concluded that these three QL test (SIP, Bulpit, Spitzer) are very useful in monitoring of treatment of the essential arterial hypertension.
Gralec
M
M
Wojewódzkiego Oddziału Kardiologii WSZ w Wałbrzychu.
Piusińska-Macoch
A
A
Cholewa
M
M
Sułek
K
K
D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001262:Atenolol / Q000627:therapeutic use; D004656:Enalapril / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011788:Quality of Life; D014700:Verapamil / Q000627:therapeutic use
D000959:Antihypertensive Agents; D001262:Atenolol; D004656:Enalapril; D014700:Verapamil